Servier Tianeptine Controversy: Revision history

22 September 2025

• curprev 14:2214:22, 22 September 2025 Beanie Bo talk contribs 4,681 bytes +309 Deletion request. Complete lack of references, overly complex jargon (breaking the granny rule), and might actually be AI. Additionally, a controversy is not an incident. Article is written more like a warning against a controversial drug that is *already illegal* in the US. Article is entirely irrelevant. undo Tag: Visual edit

21 September 2025

• curprev 05:4305:43, 21 September 2025 AnotherConsumerRightsPerson talk contribs 4,372 bytes 0 No edit summary undo

7 September 2025

• curprev 14:2414:24, 7 September 2025 AnotherConsumerRightsPerson talk contribs m 4,372 bytes 0 AnotherConsumerRightsPerson moved page Servier - Tianeptine Controversy to Servier Tianeptine Controversy: Dash isn’t needed. undo

25 March 2025

• curprev 05:3805:38, 25 March 2025 84.190.131.19 talk 4,372 bytes +583 No edit summary undo Tag: Visual edit

24 March 2025

• curprev 10:0010:00, 24 March 2025 84.190.131.19 talk 3,789 bytes +234 →References undo Tag: Visual edit
• curprev 09:5309:53, 24 March 2025 84.190.131.19 talk 3,555 bytes −531 No edit summary undo Tag: Visual edit
• curprev 09:5109:51, 24 March 2025 84.190.131.19 talk 4,086 bytes +4,086 Created page with "{{InfoboxProductLine | Title = {{PAGENAME}} | Release Year = | Product Type = | In Production = | Official Website = | Logo = }} Tianeptine is a drug marketed as an antidepressant by the french company Servier. Tianeptine has opioid like effects, leading to potential dependence and addiction. == Mechanism of Action Controversy == Initially, Servier promoted tianeptine as having a unique mechanism of action, claiming it enhanced serotonin uptake—directly opposit..." Tag: Visual edit: Switched